Barely Significant
← all excerpts

Randomized, double-blinded, placebo-controlled trial evaluating simethicone pretreatment with bowel preparation during colonoscopy.

World J Gastrointest Endosc · 2019 · PMC6580307 · PMID 31236194

1
hedged sentence
closest p
boldest claim

The sentences

Adverse events (simethicone vs placebo) such as abdominal pain/ cramping (11.9% vs 14.3%), nausea (15.5% vs 23.8%), and vomiting (4.8% vs 7.1%) were more prevalent in placebo group, however this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.